In Vivoandin VitroCorrection of themdxDystrophin Gene Nonsense Mutation by Short-Fragment Homologous Replacement
- 10 April 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (6), 629-642
- https://doi.org/10.1089/104303401300057324
Abstract
Targeted genetic correction of mutations in cells is a potential strategy for treating human conditions that involve nonsense, missense, and transcriptional splice junction mutations. One method of targeted gene repair, single-stranded short-fragment homologous replacement (ssSFHR), has been successful in repairing the common ΔF508 3-bp microdeletion at the cystic fibrosis transmembrane conductance regulator (CFTR) locus in 1% of airway epithelial cells in culture. This study investigates in vitro and in vivo application of a double-stranded method variant of SFHR gene repair to the mdx mouse model of Duchenne muscular dystrophy (DMD). A 603-bp wild-type PCR product was used to repair the exon 23 C-to-T mdx nonsense transition at the Xp21.1 dys locus in cultured myoblasts and in tibialis anterior (TA) from male mdx mice. Multiple transfection and variation of lipofection reagent both improved in vitro SFHR efficiency, with successful conversion of mdx to wild-type nucleotide at the dys locus achieved in 15 to 20% of cultured loci and in 0.0005 to 0.1% of TA. The genetic correction of mdx myoblasts was shown to persist for up to 28 days in culture and for at least 3 weeks in TA. While a high frequency of in vitro gene repair was observed, the lipofection used here appeared to have adverse effects on subsequent cell viability and corrected cells did not express dystrophin transcript. With further improvements to in vitro and in vivo gene repair efficiencies, SFHR may find some application in DMD and other genetic neuromuscular disorders in humans.Keywords
This publication has 27 references indexed in Scilit:
- In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotideNature Biotechnology, 2000
- Differential expression of dystrophin isoforms in strains of mdx mice with different mutationsHuman Molecular Genetics, 1996
- Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferationJournal of the Neurological Sciences, 1992
- A PCR‐based assay for the wild‐type dystrophin gene transferred into mdx mouseMuscle & Nerve, 1992
- An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophyGenomics, 1992
- The new mouse genetics: Altering the genome by gene targetingTrends in Genetics, 1989
- The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point MutationScience, 1989
- Altering the Genome by Homologous RecombinationScience, 1989
- Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombinationNature, 1989
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987